Patient Engagement at a Tipping Point—The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, “Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products”-Reference-Cited by-同舟云学术

Patient Engagement at a Tipping Point—The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, “Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products”

Published:2016-09 Issue:5 Volume:50 Page:546-553
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Smith Meredith Y.,Hammad Tarek A.,Metcalf Marilyn,Levitan Bennett,Noel Rebecca,Wolka Anne M.,Michaels Debra L.,Johnson F. Reed

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1177/2168479016662902.pdf

Reference34 articles.

1. Patient-Centered Outcomes Research Institute (PCORI). PCORI engagement rubric. http://www.pcori.org/sites/default/files/Engagement-Rubric.pdf. Published February 4, 2014. Accessed May 28, 2016.

2. Clinical Trials Transformation Initiative. Best practices for effective engagement with patient groups around clinical trials. http://www.ctti-clinicaltrials.org/what-we-do/investigational-plan/patient-groups. Accessed May 28, 2016.

3. Smith SK, Selig W, Harker M, et al. Patient engagement practices in clinical research among patient groups, industry, and academia in the United States: a survey. PLoS One. 2015;10:e0140232.

4. National Institutes of Health (NIH) Clinical and Translational Science Awards Consortium—Community Engagement Key Function Committee Task Force on the Principles of Community Engagement. Principles of Community Engagement. 2nd ed. http://www.atsdr.cdc.gov/communityengagement/pdf/PCE_Report_508_FINAL.pdf. Published June 2011. Accessed May 28, 2016.

5. Institute of Medicine (IOM). Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perceptions on tailored messages from a values clarification tool: a mixed-methods study of older adults with cancer;Frontiers in Communication;2024-08-07

2. Patient and Public Involvement in Pharmacovigilance;Principles and Practice of Pharmacovigilance and Drug Safety;2024

3. Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations;Pain;2023-12-19

4. Navigating a transforming landscape: the evolving role of pharmacovigilance physicians in drug development and implications for future challenges and training requirements;Frontiers in Drug Safety and Regulation;2023-09-06

5. The Burden of Pruritus Associated With CKD: A Mixed Methods Analysis Among Patients Undergoing Dialysis;Kidney Medicine;2023-09